Used primarily as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of selective receptor modulators. Its structure supports the formation of bioactive molecules targeting neurological and psychiatric disorders. The compound’s bromo and ether functional groups allow for further chemical modifications, making it valuable in medicinal chemistry for creating analogs with enhanced binding affinity and selectivity. It is also employed in research settings to develop novel compounds for central nervous system therapies.